Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

E2F6

Identity

Other namesE2F-6
E2F transcription factor 6
E2 Binding Factor 6
HGNC E2F6
Location 2p25.1

DNA/RNA

Description In humans, E2F6 has 8 exons that span 20881 bp of genomic sequence. It has an ORF of 843 nt.
Transcription There have been 5 mRNA splice variants identified in humans.
  • Transcript variant 1 is the predominant transcript, and it encodes the longest mRNA isoform (a), which is 2342 bp.
  • Transcript variant 2 contains an additional segment (2413 bp mRNA), compared to variant 1, that causes a frameshift leading to an early stop codon. This transcript may function in a regulatory role with no protein translated. The predicted protein (isoform b) is much shorter than isoform a. Transcript variants 2 and 4 encode isoform b.
  • Transcript variant 3 lacks a segment (2287 bp mRNA), compared to variant 1, that causes a frameshift leading to an early stop codon. This transcript may function in a regulatory role with no protein translated. The predicted protein (isoform c) is much shorter than isoform a.
  • Transcript variant 4 contains two additional segments (2546 bp mRNA), compared to variant 1, that cause a frameshift leading to an early stop codon. This transcript may function in a regulatory role with no protein translated. The predicted protein (isoform b) is much shorter than isoform a.
  • Transcript variant 5 contains an additional segment (2475 bp mRNA), compared to variant 1, that causes a frameshift leading to an early stop codon. This transcript may function in a regulatory role with no protein translated. The predicted protein (isoform d) is much shorter than isoform a.
  • Pseudogene There is an E2F6 pseudogene located on chromosome 22q11.2 (LOC376818) containing 2144 bp of the E2F6 gene with no introns.

    Protein

     
      Diagram created by M. Oberley.
    Description The predominately expressed isoform is 282 amino acids, and is . The DNA binding domain is thought to be between aa 50 and 129. It has a DEF box between aa 95 to 195. The dimerization domain is thought to reside between aa 130 and 222. There is a leucine zipper domain between aa 143 and 164. The transcriptional repression domain is located on the C terminus from aa 173 to 281. The N-terminal 1-75 aa are missing in isoform B which is predicted to be 206 AA.
    Expression Ubiquitous, though more highly expressed in the placenta, skeletal muscle, heart, ovary, kidney, small intestine and spleen.
    Localisation Nuclear
    Function Heterodimerization with DP1 or 2 creates a sequence specific transcriptional repressor. Overexpression of E2F6 can delay the exit of cells from S-phase, indicating a role for E2F6 in cell-cycle control. E2F6 has been shown via yeast two hybrid and co-IPs to interact with members of the polycomb repressive complex 1, such as Bmi1, RYBP, RING1, MEL-18, and Mph1. The functional outcome of these interactions are as of yet unclear. E2F6 has been biochemically purified in a complex containing polycomb group members h-1(3) mbt like protein, RING1, RING2, hMBLR, as well as YAF and HP1g; this complex also contained a novel euchromatic histone methyltransferase (Eu-HMTase1). This finding led to speculation that E2F6 controlled cellular entry into quiescence, but E2F6 nullizygous MEFs had no kinetic changes or defects in their ability to enter quiescence, or to re-enter into the cell-cycle. However, these animals had homeotic transformations of the axial skeleton, a phenotype that resembled Bmi1 nullizygous mice. This implicated E2F6 in regulation of normal development.
    Homology E2F6 has homology with E2Fs1-5 in the DNA-binding domain, the dimerization domain, and the marked box domain located between aa 231 and 239.

    Mutations

    Note A synthetic mutation in aa 68; L->E: reduced E2F6 transcriptional repressor activity by abrogating DNA binding, but had little effect on S-phase entry.

    Implicated in

    Entity Development
    Note E2F6 is required for normal homeotic development in murine models as mice nullizygous for E2F6 display transformations in the axial skeleton.
    Disease None known.
      

    External links

    Nomenclature
    HGNCE2F6   3120
    Entrez_GeneE2F6  1876  E2F transcription factor 6
    Cards
    AtlasE2F6ID521
    GeneCardsE2F6
    EnsemblE2F6 [Search_View]   ENSG00000169016 [Gene_View]
    GenatlasE2F6
    GeneLynxE2F6
    eGenomeE2F6
    euGene1876
    Genomic and cartography
    GoldenPathE2F6  -  2p25.1   chr2:11501952-11523748 -  2p25.1   [Description]    (hg18-Mar_2006)
    EnsemblE2F6 - 2p25.1 [CytoView]
    NCBIMapview
    OMIMDisease map [OMIM]
    HomoloGeneE2F6
    Gene and transcription
    GenbankAF041381 [ ENTREZ ]
    GenbankAF059292 [ ENTREZ ]
    GenbankAF088059 [ ENTREZ ]
    GenbankAK096197 [ ENTREZ ]
    GenbankAK223159 [ ENTREZ ]
    RefSeqNM_198256 [ SRS ]    NM_198256 [ ENTREZ ]
    RefSeqAC_000045 [ SRS ]    AC_000045 [ ENTREZ ]
    RefSeqAC_000134 [ SRS ]    AC_000134 [ ENTREZ ]
    RefSeqNC_000002 [ SRS ]    NC_000002 [ ENTREZ ]
    RefSeqNT_005334 [ SRS ]    NT_005334 [ ENTREZ ]
    RefSeqNW_001838766 [ SRS ]    NW_001838766 [ ENTREZ ]
    RefSeqNW_927719 [ SRS ]    NW_927719 [ ENTREZ ]
    AceViewE2F6 AceView - NCBI
    UnigeneHs.603093 [ SRS ]    Hs.603093 [ NCBI ]     HS603093 [ spliceNest ]
    Fast-db1415 (alternative variants)
    Protein : pattern, domain, 3D structure
    SwissProtO75461 [ SRS]    O75461 [ EXPASY ]     O75461 [ INTERPRO ]     O75461 [ UNIPROT ]
    InterproIPR015633 E2F [ SRS ]    IPR015633 E2F [ EBI ]
    InterproIPR015635 E2F6 [ SRS ]    IPR015635 E2F6 [ EBI ]
    InterproIPR003316 E2F_TDP [ SRS ]    IPR003316 E2F_TDP [ EBI ]
    InterproIPR011991 Wing_hlx_DNA_bd [ SRS ]    IPR011991 Wing_hlx_DNA_bd [ EBI ]
    CluSTrO75461
    PfamPF02319 E2F_TDP [ SRS ]    PF02319 E2F_TDP [ Sanger ]    pfam02319 [ NCBI-CDD ]
    BlocksO75461
    HPRD04251
    Protein Interaction databases
    DIPO75461
    IntActO75461
    Polymorphism : SNP, mutations, diseases
    OMIM602944    [ map ]   
    GENECLINICS602944
    SNPE2F6 [dbSNP-NCBI]  
    SNPNM_198256 [SNP-NCI]  
    SNPE2F6 [GeneSNPs - Utah]  E2F6] [HGBASE - SRS]
    HAPMAPE2F6 [HAPMAP]  
    COSMICE2F6 [Somatic mutation (COSMIC-CGP-Sanger)]  
    HGMDE2F6
    General knowledge
    Family BrowserE2F6 [UCSC Family Browser]
    SOURCENM_198256
    SMDHs.603093
    SAGEHs.603093
    GOnegative regulation of transcription from RNA polymerase II promoter [Amigo]  negative regulation of transcription from RNA polymerase II promoter
    GOtranscription factor activity [Amigo]  transcription factor activity
    GOtranscription corepressor activity [Amigo]  transcription corepressor activity
    GOnucleus [Amigo]  nucleus
    GOtranscription factor complex [Amigo]  transcription factor complex
    GOtranscription [Amigo]  transcription
    GOregulation of transcription, DNA-dependent [Amigo]  regulation of transcription, DNA-dependent
    GOcell cycle [Amigo]  cell cycle
    PubGeneE2F6
    TreeFamE2F6
    CTD1876 [Comparative ToxicoGenomics Database]
    Other databases
    Probes
    ProbeE2F6 Related clones (RZPD - Berlin)
    PubMed
    PubMed22 Pubmed reference(s) in LocusLink

    Bibliography

    An E2F-like repressor of transcription.
    Morkel M, Wenkel J, Bannister AJ, Kouzarides T, Hagemeier C
    Nature. 1997 ; 390 (6660) : 567-568.
    PMID 9403682
     
    E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
    Cartwright P, Mˆºller H, Wagener C, Holm K, Helin K
    Oncogene. 1998 ; 17 (5) : 611-623.
    PMID 9704927
     
    Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6.
    Gaubatz S, Wood JG, Livingston DM
    Proceedings of the National Academy of Sciences of the United States of America. 1998 ; 95 (16) : 9190-9195.
    PMID 9689056
     
    E2F-6, a member of the E2F family that can behave as a transcriptional repressor.
    Trimarchi JM, Fairchild B, Verona R, Moberg K, Andon N, Lees JA
    Proceedings of the National Academy of Sciences of the United States of America. 1998 ; 95 (6) : 2850-2855.
    PMID 9501179
     
    Molecular cloning and characterization of the mouse E2F6 gene.
    Kherrouche Z, Begue A, Stehelin D, Montˆ© D
    Biochemical and biophysical research communications. 2001 ; 288 (1) : 22-33.
    PMID 11594747
     
    The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex.
    Trimarchi JM, Fairchild B, Wen J, Lees JA
    Proceedings of the National Academy of Sciences of the United States of America. 2001 ; 98 (4) : 1519-1524.
    PMID 11171983
     
    Two different E2F6 proteins generated by alternative splicing and internal translation initiation.
    Dahme T, Wood J, Livingston DM, Gaubatz S
    European journal of biochemistry / FEBS. 2002 ; 269 (20) : 5030-5036.
    PMID 12383262
     
    A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells.
    Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y
    Science (New York, N.Y.). 2002 ; 296 (5570) : 1132-1136.
    PMID 12004135
     
    Homeotic transformations of the axial skeleton that accompany a targeted deletion of E2f6.
    Storre J, Elsˆ§sser HP, Fuchs M, Ullmann D, Livingston DM, Gaubatz S
    EMBO reports. 2002 ; 3 (7) : 695-700.
    PMID 12101104
     
    Sibling rivalry in the E2F family.
    Trimarchi JM, Lees JA
    Nature reviews. Molecular cell biology. 2002 ; 3 (1) : 11-20.
    PMID 11823794
     
    Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters.
    Caretti G, Salsi V, Vecchi C, Imbriano C, Mantovani R
    The Journal of biological chemistry. 2003 ; 278 (33) : 30435-30440.
    PMID 12771133
     
    E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9.
    Oberley MJ, Inman DR, Farnham PJ
    The Journal of biological chemistry. 2003 ; 278 (43) : 42466-42476.
    PMID 12909625
     
    REVIEW articlesautomatic search in PubMed
    Last year publicationsautomatic search in PubMed

    Search in all EBI   NCBI

    Contributor(s)

    Written03-2004Matthew Oberley
    McArdle Laboratory for Cancer Research, University of Wisconsin - Madison, 1400 University Ave. Madison, WI 53706, USA

    Citation

    This paper should be referenced as such :
    Oberley M . E2F6. Atlas Genet Cytogenet Oncol Haematol. March 2004 .
    URL : http://AtlasGeneticsOncology.org/Genes/E2F6ID521.html

    © Atlas of Genetics and Cytogenetics in Oncology and Haematology
    indexed on : Mon Aug 11 21:13:25 2008


    Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

    For comments and suggestions or contributions, please contact us

    j.l.huret@chu-poitiers.fr.